Transparency is the prerequisite for building trust with the public and the patients. Therefore, from July 2017, Mylan and the legal entities Mylan UK Healthcare Limited, Generics UK Limited and MEDA Pharmaceuticals Limited (UK) will disclose the monetary benefits between these entities and the players in the healthcare sector.
You are now leaving the Mylan United Kingdom site for another Mylan affiliate site or a third party site that is solely responsible for its content and may not follow guidelines applicable in certain geographies. Links to Mylan affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site. Regulatory requirements, data requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country. Mylan United Kingdom accepts no responsibility for the content of other sites.